Innopeutics is a biotech company established with the mission to combat human diseases through innovative therapeutic development. Our primary objective is to revolutionize the drug development process through advanced knowledge and a collaborative R&D culture, ultimately bringing happiness and hope to patients and their families.
Drawing upon several years of dedicated work on our proprietary AAV (Adeno-associated virus) manufacturing platform, Innopeutics is actively advancing therapies for neurodegenerative diseases, autoimmune disorders, and cancer. Our leading pipeline includes the IPS-101/102 programs, targeting Parkinson's and Alzheimer's diseases, with the first-in-human study scheduled for 2025.
At Innopeutics, our core values are centered around the well-being of patients and their families. We are committed to ceaseless R&D efforts for their benefit, and we aspire to help patients and their families create cherished memories through our innovative therapies.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Seoul, Kr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://innopeutics.com
- HQ
- Seoul
Innopeutics Corporation Questions
Innopeutics Corporation's website is http://innopeutics.com
Innopeutics Corporation's LinkedIn profile is https://kr.linkedin.com/company/innopeutics
Innopeutics Corporation has
2 employees.
View email and phone details for 2
employees at Innopeutics Corporation.
Innopeutics Corporation's industry is
Biotechnology Research
Innopeutics Corporation's top competitors are
Toolgen Inc.,
Pharmaresearch Co. Ltd.,
Illuminare Biotechnologies,
Sansho Co., Ltd.,
Sanobio Therapeutics,
Meta Pharmaceuticals Inc.,
Topelia,
Medicibio Co.,ltd,
Abm Therapeutics,
Gempharmatech Asia Pacific.
Innopeutics Corporation's categories are Biotechnology Research
Innopeutics Corporation's founding year is 2019
